Professional boxer Krzysztof Glowacki receives four-year ban for Anti-Doping Rule Violations
Polish professional boxer Krzysztof Glowacki has been banned from all sport for a period of four years following Anti-Doping Rule Violations (ADRVs) for the Presence and Use of a Prohibited Substance.
On 21 January 2023, UKAD collected an In-Competition urine Sample from Mr Glowacki after his fight against Richard Riakporhe at the AO Arena in Manchester. Analysis of Mr Glowacki’s Sample returned an Adverse Analytical Finding (AAF) for boldenone and its Metabolite, 17β-hydroxy-5β-androst-1-en-3-one.
Boldenone is listed under section S1 of the World Anti-Doping Agency (WADA) 2023 Prohibited List as an anabolic androgenic steroid. It is a non-Specified substance that is prohibited in sport at all times.
On 6 April 2023, UKAD notified Mr Glowacki that he may have committed two ADRVs contrary to Article 2.1 (Presence of a Prohibited Substance in an Athlete’s Sample) and 2.2 (Use or Attempted Use by an Athlete of a Prohibited Substance or Prohibited Method) of the 2021 UK Anti-Doping Rules (‘ADR’). UKAD also provisionally suspended Mr Glowacki from all Code-compliant sport from this date.
On 2 June 2023, UKAD charged Mr Glowacki with both ADRVs. Mr Glowacki responded on 12 June 2023, denying the ADRVs and asserting that he had not taken any Prohibited Substance.
Mr Glowacki’s case was heard by the independent National-Anti-Doping Panel (NADP) on 31 October 2023. The NADP issued a decision on 21 November 2023 which imposed a period of Ineligibility of four years. Mr Glowacki’s period of Ineligibility commenced on 6 April 2023 and will expire at 11:59pm on 5 April 2027.
Speaking on the case, Hamish Coffey, UKAD Director of Operations said: “It is very important that athletes respect the rules and understand their responsibilities to uphold clean sport. Boldenone, as with all steroids, is performance enhancing and undermines the integrity of sport. There is no place for steroids in sport.”
